PATENT CLAIM ANALYSIS

Application Number: 15990561
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "093210"]

Abstract:
Provided herein are modified T lymphocytes comprising chimeric receptors and methods of use thereof.

Claim (Index 26):
The modified T lymphocyte of  claim 1 , wherein said first polypeptide comprises an extracellular tumor antigen-binding domain and a CD3\u03b6 signaling domain, and wherein said second polypeptide comprises an antigen-binding domain wherein said antigen is an angiogenic or vasculogenic factor, and one or more co-stimulatory molecule signaling motifs.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14653650', '14775891', '15550645', '14873836', '14516880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.743071456558356
- 35 USC 102 Novelty (BERT): 0.575605665709708
- Combined Prediction Score: 0.7263248774734912
- Mean Citation Score: 390.335344
- Max Citation Score: 464.99088
- Similarity Product: 384.05812103925706

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test